Home
AstraZeneca Strengthens its Cardiovascular Pipeline with Agreement for a Pre-Clinical Novel Lipid-Lowering Therapy

AstraZeneca Strengthens its Cardiovascular Pipeline with Agreement for a Pre-Clinical Novel Lipid-Lowering Therapy

Impacting News October 8, 2024

AstraZeneca Agreement with CSPC Pharmaceutical Group
Yesterday, October 7, 2024, AstraZeneca (AZN) announced it entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd (CSPC) to advance . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.
Impacting News
,
October 8, 2024

Other Articles